XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

Discover how personalized care is revolutionizing bipolar I management. explore new treatments offering hope for lasting ...

Although everyone’s CLL journey is different, there tend to be shared milestones that can give patients a sense of progress, as well as resilience, when navigating treatment options. Here’s what ...

Biologic treatments are a new option for people with moderate to severe eczema or atopic dermatitis. Most people can control eczema with prevention techniques, topical treatments, or ultraviolet ...

New treatments for macular degeneration may help preserve your eyesight for longer, without the need for frequent injections. Some of these treatments include retinal gene therapy and the "port" ...

Getting your blood tested for uric acid levels may be part of a bigger medical workup when your doctor is concerned you might have gout or another ... These treatments kill a lot of cells in ...

But now it’s well established that the symptoms can persist into adulthood — and a large new study has assessed which treatments may be most effective at alleviating them. Stimulant ...

Stimulant drugs and another medication – atomoxetine – appear to be the best treatment for managing symptoms ... population in the UK have ADHD. The new study, published in The Lancet ...

Teenage sprint sensation Gout Gout is a ‘huge attraction’ for potential new fans of athletics, according to the man who runs the sport, Lord Coe. The Australian turned heads earlier this month ...

Join us to hear from Dr Emma Mead about the work of our Drug Discovery Alliance, and Dr Joyce Huang about the potential benefits of repurposing existing treatments for other conditions. They'll answer ...

For gout, xanthine oxidase (XO ... Maybe we are coming to a new era of [treatment, with] remission induction driving the serum urate very low, and then a maintenance therapy where we can back ...

An Ottawa doctor’s race to find a last-chance treatment for a patient fighting an artificial joint infection could help spark a Canadian resurgence of an old therapy to treat new medical issues.